Dr. Sharer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
824 Main St
Ste 101
Phoenixville, PA 19460Phone+1 610-983-1800Fax+1 610-983-1799
Education & Training
- Main Line Health System/Lankenau Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1985
- McLaren Health Care/Greater Lansing/MSUFellowship, Hematology and Medical Oncology, 1982 - 1984
- Mercy Catholic Medical CenterResidency, Internal Medicine, 1979 - 1982
- Philadelphia College of Osteopathic MedicineClass of 1978
Certifications & Licensure
- NJ State License Current
- PA State License 1979 - 2024
- DE State License 2018 - 2019
- MI State License 1982 - 1986
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Start of enrollment: 2006 Oct 01
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Join now to see all
Publications & Presentations
PubMed
- 56 citationsRandomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SW...N. Lynn Henry, Joseph M. Unger, Anne F. Schott, Louis Fehrenbacher, Patrick J. Flynn
Journal of Clinical Oncology. 2017-11-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: